Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    June 2018
  1. NATTEL S
    Catheter ablation of atrial fibrillation and outcomes in heart failure patients: seeking the treasure in the CASTLE.
    Cardiovasc Res. 2018;114:e50-e52.
    PubMed     Text format    


    April 2018
  2. BORGOGNONE A, Shantsila E, Worrall SM, Prompunt E, et al
    Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
    Cardiovasc Res. 2018 Apr 12. pii: 4969512. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. BARICHELLO S, Roberts JD, Backx P, Boyle P, et al
    Personalizing Therapy for Atrial Fibrillation: the Role of Stem Cell and in Silico Disease Models.
    Cardiovasc Res. 2018 Apr 10. pii: 4966930. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  4. DOBREV D, Lorenz K
    Age-dependent Increase in JNK2 Activity: Does This Help to Understand CaMKII-mediated Atrial Arrhythmogenesis in Human Atrial Fibrillation?
    Cardiovasc Res. 2018 Feb 8. pii: 4844871. doi: 10.1093.
    PubMed     Text format    


    December 2017
  5. BRUEGMANN T, Beiert T, Vogt CC, Schrickel JW, et al
    Optogenetic termination of atrial fibrillation in mice.
    Cardiovasc Res. 2017 Dec 23. pii: 4774318. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  6. WESTERHOF BE, Saouti N, van der Laarse WJ, Westerhof N, et al
    Treatment strategies for the right heart in pulmonary hypertension.
    Cardiovasc Res. 2017;113:1465-1473.
    PubMed     Text format     Abstract available


    June 2017
  7. PORTERO V, Casini S, Hoekstra M, Verkerk AO, et al
    Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
    Cardiovasc Res. 2017;113:829-838.
    PubMed     Text format     Abstract available


  8. SHATTOCK MJ, Park KC, Yang HY, Lee AWC, et al
    Restitution slope is principally determined by steady-state action potential duration.
    Cardiovasc Res. 2017;113:817-828.
    PubMed     Text format     Abstract available


    May 2017

  9. Corrigendum to: Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
    Cardiovasc Res. 2017;113:691.
    PubMed     Text format    


    April 2017
  10. SOSSALLA S
    Ablation outperforming antiarrhythmic drugs need for more research.
    Cardiovasc Res. 2017;113:e4-e5.
    PubMed     Text format    


  11. DERANGEON M, Montnach J, Cerpa CO, Jagu B, et al
    Transforming growth factor beta receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
    Cardiovasc Res. 2017;113:464-474.
    PubMed     Text format     Abstract available


    March 2017
  12. WATANABE M, Feola I, Majumder R, Jangsangthong W, et al
    Optogenetic manipulation of anatomical re-entry by light-guided generation of a reversible local conduction block.
    Cardiovasc Res. 2017;113:354-366.
    PubMed     Text format     Abstract available


  13. KIM TY, Terentyeva R, Roder KH, Li W, et al
    SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyR.
    Cardiovasc Res. 2017;113:343-353.
    PubMed     Text format     Abstract available


  14. ZHAO YT, Guo YB, Gu L, Fan XX, et al
    Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes.
    Cardiovasc Res. 2017;113:332-342.
    PubMed     Text format     Abstract available


  15. VERMIJ SH, Abriel H, van Veen TA
    Refining the molecular organization of the cardiac intercalated disc.
    Cardiovasc Res. 2017;113:259-275.
    PubMed     Text format     Abstract available


    February 2017
  16. CHEN Y, Surinkaew S, Naud P, Qi XY, et al
    JAK-STAT signaling and the atrial fibrillation promoting fibrotic substrate.
    Cardiovasc Res. 2017 Feb 2. doi: 10.1093.
    PubMed     Text format    


  17. ROCCHETTI M, Sala L, Dreizehnter L, Crotti L, et al
    Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Cardiovasc Res. 2017 Feb 2. doi: 10.1093.
    PubMed     Text format    


    January 2017
  18. TE RIELE AS, Agullo-Pascual E, James CA, Leo-Macias A, et al
    Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
    Cardiovasc Res. 2017;113:102-111.
    PubMed     Text format     Abstract available


    May 2016
  19. BOBIN P, Varin A, Lefebvre F, Fischmeister R, et al
    Calmodulin kinase II inhibition limits the pro-arrhythmic Ca2+ waves induced by cAMP-phosphodiesterase inhibitors.
    Cardiovasc Res. 2016;110:151-61.
    PubMed     Text format     Abstract available


    April 2016
  20. NATTEL S
    How does Fibrosis Promote Atrial Fibrillation Persistence: In Silico Findings, Clinical Observations and Experimental Data.
    Cardiovasc Res. 2016.
    PubMed     Text format    


  21. ZAHID S, Cochet H, Boyle PM, Schwarz EL, et al
    Patient-derived models link reentrant driver localization in atrial fibrillation to fibrosis spatial pattern.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  22. SIPIDO KR
    Spotlight on atrial fibrillation in Cardiovascular Research.
    Cardiovasc Res. 2016;109:463-4.
    PubMed     Text format    


    March 2016
  23. LINZ D, Hohl M, Dhein S, Ruf S, et al
    Cathepsin A Mediates Susceptibility to Atrial Tachyarrhythmia and Impairment of Atrial Emptying Function in Zucker Diabetic Fatty Rats.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  24. ALLENDE M, Molina E, Guruceaga E, Tamayo I, et al
    Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    February 2016
  25. NATTEL S, Dobrev D
    Deciphering the fundamental mechanisms of atrial fibrillation: a quest for over a century.
    Cardiovasc Res. 2016.
    PubMed     Text format    


    January 2016
  26. HATEM SN, Redheuil A, Gandjbakhch E
    Cardiac adipose tissue and atrial fibrillation: the perils of adiposity.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  27. OPACIC D, van Bragt KA, Nasrallah HM, Schotten U, et al
    Atrial metabolism and tissue perfusion as determinants of electrical and structural remodeling in atrial fibrillation.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  28. SIMON JN, Ziberna K, Casadei B
    Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  29. GUILLEM MS, Climent AM, Rodrigo M, Fernandez-Aviles F, et al
    Presence and Stability of Rotors in Atrial Fibrillation: Evidence and Therapeutic Implications.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  30. LI N, Dobrev D, Wehrens XH
    PITX2: a master regulator of cardiac channelopathy in atrial fibrillation?
    Cardiovasc Res. 2016.
    PubMed     Text format    


  31. MESUBI OO, Anderson ME
    Atrial remodeling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  32. MA JF, Yang F, Mahida SN, Zhao L, et al
    TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  33. TUCKER NR, Clauss S, Ellinor PT
    Common Variation in Atrial Fibrillation: Navigating the Path from Genetic Association to Mechanism.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  34. YAMADA C, Kuwahara K, Yamazaki M, Nakagawa Y, et al
    The renin-angiotensin system promotes arrhythmogenic substrates and lethal arrhythmias in mice with non-ischaemic cardiomyopathy.
    Cardiovasc Res. 2016;109:162-73.
    PubMed     Text format     Abstract available


    December 2015
  35. PEREZ-HERNANDEZ M, Matamoros M, Barana A, Amoros I, et al
    Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  36. HEIJMAN J, Algalarrondo V, Voigt N, Melka J, et al
    The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: A critical analysis.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  37. KANT S, Krusche C, Gaertner A, Milting H, et al
    Loss of plakoglobin immunoreactivity in intercalated discs in arrhythmogenic right ventricular cardiomyopathy: Protein mislocalization versus epitope masking.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  38. ZHANG D, Hu X, Henning RH, Brundel BJ, et al
    Keeping up the balance: Role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  39. RUDOLPH TK, Ravekes T, Klinke A, Friedrichs K, et al
    Nitrated fatty acids suppress angiotensin II mediated fibrotic remodeling and atrial fibrillation.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    June 2015
  40. BEHR ER, Savio-Galimberti E, Barc J, Holst AG, et al
    Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.
    Cardiovasc Res. 2015;106:520-9.
    PubMed     Text format     Abstract available


  41. ABRIEL H
    Genetic background of Brugada syndrome is more complex than what we would like it to be!
    Cardiovasc Res. 2015;106:351-2.
    PubMed     Text format    


    May 2015
  42. VOGT CC, Bruegmann T, Malan D, Ottersbach A, et al
    Systemic gene transfer enables optogenetic pacing of mouse hearts.
    Cardiovasc Res. 2015;106:338-43.
    PubMed     Text format     Abstract available


    April 2015
  43. PLUTEANU F, Hess J, Plackic J, Nikonova Y, et al
    Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive rats.
    Cardiovasc Res. 2015;106:87-97.
    PubMed     Text format     Abstract available


  44. MAIER LS
    Some 'brain' in the heart: a novel microdomain with neuronal Na channels responsible for arrhythmias?
    Cardiovasc Res. 2015;106:4-5.
    PubMed     Text format    


  45. DOLESCHAL B, Primessnig U, Wolkart G, Wolf S, et al
    TRPC3 contributes to regulation of cardiac contractility and arrhythmogenesis by dynamic interaction with NCX1.
    Cardiovasc Res. 2015;106:163-73.
    PubMed     Text format     Abstract available


  46. RADWANSKI PB, Brunello L, Veeraraghavan R, Ho HT, et al
    Neuronal Na+ channel blockade suppresses arrhythmogenic diastolic Ca2+ release.
    Cardiovasc Res. 2015;106:143-52.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: